| An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence … PA Dickinson, R Abu Rmaileh, L Ashworth, RA Barker, WM Burke, ... The AAPS journal 14 (2), 196-205, 2012 | 122 | 2012 |
| Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation AT Larsen, AG Ohlsson, B Polentarutti, RA Barker, AR Phillips, ... European Journal of Pharmaceutical Sciences 48 (1-2), 339-350, 2013 | 112 | 2013 |
| Application and validation of an advanced gastrointestinal in vitro model for the evaluation of drug product performance in pharmaceutical development R Barker, B Abrahamsson, M Kruusmägi Journal of pharmaceutical sciences 103 (11), 3704-3712, 2014 | 77 | 2014 |
| Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part II. A mechanistic PBPK model for IR formulation comparison, proton pump inhibitor drug interactions … XJH Pepin, AJ Moir, JC Mann, NJ Sanderson, R Barker, E Meehan, ... European journal of pharmaceutics and biopharmaceutics 142, 435-448, 2019 | 37 | 2019 |
| Using computational fluid dynamics to compare shear rate and turbulence in the TIM-automated gastric compartment with USP apparatus II M Hopgood, G Reynolds, R Barker Journal of Pharmaceutical Sciences 107 (7), 1911-1919, 2018 | 28 | 2018 |
